Ohio Adult Use Cannabis Program — Regulations, Dispensaries & Market Guide

Executive Summary

Ohio's adult-use cannabis program, which launched sales on August 6, 2024, represents a $4 billion market opportunity serving a state of 11.8 million residents. The program emerged from Issue 2, a citizen-initiated ballot measure approved by 57% of voters in November 2023, making Ohio the 24th state to legalize recreational cannabis. The Division of Cannabis Control within the Ohio Department of Commerce oversees licensing, testing, and compliance for approximately 130 operational dispensaries as of September 2026. Adults 21 and older may purchase up to 2.5 ounces of cannabis flower per transaction, with possession limits capped at 2.5 ounces outside the home. The program generated $274 million in sales during its first year, with tax revenue allocated to administrative costs, social equity programs, municipalities hosting dispensaries, and substance abuse treatment. Recent enforcement actions, including the September 2026 closure of an unnamed dispensary following reports of serious adverse health reactions, underscore ongoing regulatory challenges as Ohio transitions from a medical-only framework to dual-market operations. The state's approach prohibits home cultivation for recreational users, distinguishes it from most adult-use jurisdictions, and creates continued dependence on licensed retail channels.

Why This Matters

Ohio's adult-use program affects 11.8 million residents, employs approximately 15,000 workers across cultivation, processing, testing, and retail operations, and represents the largest new cannabis market launch east of the Mississippi since New Jersey in 2022. The state's geographic position as a Midwest bellwether influences policy debates in neighboring Pennsylvania, Kentucky, and Indiana, where legalization efforts remain stalled. For patients, the program expanded access by converting the state's 130 medical dispensaries to dual-license operations, eliminating the $50 annual medical card fee burden for casual users while preserving higher possession limits and lower tax rates for registered patients. Medical cardholders retain the ability to purchase up to 90-day supplies as determined by physicians, compared to the 2.5-ounce per-transaction limit for adult-use customers. For operators, Ohio's decision to grant existing medical license holders first priority for adult-use certificates created immediate market expansion opportunities without the uncertainty of new lottery systems. Multi-state operators including Cresco Labs, Curaleaf, and Verano Holdings expanded Ohio footprints through 2024-2025 acquisitions, with transaction multiples reaching 8-12x EBITDA for profitable dispensary portfolios. Wholesale prices declined 35-40% in the first year as cultivators ramped production to meet recreational demand, compressing margins for smaller operators without vertical integration. For municipalities, the program provides new revenue streams through local sales taxes of up to 3%, which more than 80 Ohio cities and townships enacted by mid-2025. Cleveland, Columbus, Cincinnati, and Toledo collectively project $45-60 million in annual cannabis tax revenue by 2027, funding infrastructure, public safety, and economic development initiatives.

Background and History

Medical Program Foundation (2016-2023)

Ohio's path to adult-use legalization began with House Bill 523, signed into law by Governor John Kasich on June 8, 2016, establishing a medical cannabis program that took two years to operationalize. The legislation created a vertically integrated licensing structure with separate certificates for cultivation (Level I facilities up to 25,000 square feet, Level II up to 3,000 square feet), processing, testing, and dispensing. The Ohio Medical Marijuana Control Program, housed within the State Board of Pharmacy, issued the first cultivator licenses in November 2017 and the first dispensary licenses in March 2018. Sales commenced on January 16, 2019, at 56 operational dispensaries serving patients with 21 qualifying conditions including cancer, chronic pain, PTSD, and epilepsy. The program grew steadily but faced criticism for high costs, limited product availability, and restrictive qualifying conditions. By December 2022, Ohio registered approximately 235,000 active medical cardholders purchasing $400 million annually, ranking the state 12th nationally in per-capita medical cannabis sales.

Issue 2 Campaign and Passage (2023)

The Coalition to Regulate Marijuana Like Alcohol filed petitions with the Ohio Attorney General on November 28, 2022, launching the citizen-initiated statute that would become Issue 2. The coalition, backed by national advocacy groups including the Marijuana Policy Project and local organizations such as Ohioans for Cannabis Legalization, collected 222,000 valid signatures by July 2023, exceeding the 132,887 required to place the measure on the November 2023 ballot. Issue 2 proposed legalizing possession of up to 2.5 ounces of cannabis flower and 15 grams of concentrate for adults 21 and older, establishing a 10% excise tax on sales, and directing the Division of Cannabis Control to issue adult-use licenses. The measure explicitly prohibited home cultivation, a compromise designed to secure support from law enforcement and municipal leaders concerned about unregulated production. Opponents, led by the Coalition for a Healthy and Safe Ohio and funded primarily by opioid treatment providers and conservative advocacy groups, raised $7 million arguing that legalization would increase youth access, impaired driving, and workplace safety incidents. Proponents spent $24 million on television advertising, digital outreach, and grassroots organizing emphasizing criminal justice reform, tax revenue, and personal freedom. On November 7, 2023, Ohio voters approved Issue 2 with 57% support, carrying 67 of 88 counties including all major metropolitan areas. The measure took effect December 7, 2023, immediately legalizing possession and use while requiring the Division of Cannabis Control to establish regulatory frameworks for commercial sales within nine months.

Regulatory Implementation (December 2023 - August 2024)

The Division of Cannabis Control, created by Issue 2 and transferred from the Department of Commerce's existing medical oversight structure, published emergency rules on January 12, 2024, outlining the dual-license application process. Existing medical license holders received priority through a 60-day exclusive application window opening February 1, 2024, during which 98% of medical dispensaries applied for adult-use certificates. The Division approved the first adult-use dispensary licenses on May 15, 2024, to 127 existing medical operators, requiring facility modifications including separate point-of-sale systems, dedicated inventory tracking, and enhanced security protocols. Cultivators received approval to expand canopy by an average of 40% to meet projected demand, with total licensed cultivation space reaching 2.1 million square feet by July 2024. Testing laboratories, which numbered 15 statewide, implemented expanded panels for adult-use products including mandatory mycotoxin, heavy metal, and residual solvent screening beyond the medical program's requirements. The Division set action limits for pesticides at 0.1 ppm for any compound not explicitly approved for cannabis cultivation, stricter than medical standards and aligned with California and Colorado protocols.

Launch and First Year Operations (August 2024 - August 2025)

Adult-use sales began August 6, 2024, at 98 dispensaries statewide, generating $11.5 million in first-week revenue and drawing lines of 200-300 customers at major metropolitan locations. The Division reported 1.2 million transactions in the first month, with average basket sizes of $87 compared to $112 for medical purchases, reflecting recreational consumers' preference for lower-cost flower products and pre-rolls over concentrates and edibles. Supply constraints emerged in September-October 2024 as cultivators underestimated demand, leading to temporary product shortages and wholesale price spikes of 25-30% for popular strains including Wedding Cake, Garlic Cookies, and Sunset Sherbet. The Division responded by approving emergency canopy expansions for 12 Level I cultivators, adding 400,000 square feet of production capacity that came online in Q1 2025. By August 2025, the program stabilized with 130 operational dispensaries, 38 cultivators, 42 processors, and 15 testing laboratories. Total sales reached $274 million in year one, below initial projections of $350-400 million but consistent with conservative ramp scenarios. Medical sales declined 15% as approximately 35,000 patients transitioned to adult-use purchasing to avoid the $50 annual card renewal fee, despite higher tax rates.

Ongoing Developments (September 2025 - Present)

The Division of Cannabis Control initiated 47 enforcement actions between September 2025 and September 2026, including license suspensions, civil penalties, and product recalls, reflecting maturation of compliance infrastructure. Common violations included inventory tracking discrepancies, failure to maintain video surveillance, and sale to individuals under 21. The September 2026 closure of an unnamed dispensary following reports of serious adverse health reactions marked the program's first public health emergency, triggering product holds and expanded testing protocols. Legislative efforts to permit home cultivation for adult-use consumers failed in the 2025-2026 session despite support from 62% of Ohioans in March 2026 polling. House Bill 447, which would have allowed cultivation of up to six plants per adult with a 12-plant household maximum, passed the House 58-41 but stalled in the Senate amid opposition from the Ohio Chamber of Commerce and licensed cultivator trade associations.

Key Players

Division of Cannabis Control

The Division of Cannabis Control, led by Director James Canepa since January 2024, operates within the Ohio Department of Commerce with a $28 million annual budget funded by license fees and application charges. The Division employs 87 full-time staff including compliance investigators, licensing specialists, and data analysts responsible for regulating approximately 225 active licenses across cultivation, processing, testing, and retail categories. The Division maintains a public-facing database at medicalmarijuana.ohio.gov tracking all licensed facilities, enforcement actions, and testing results.

Multi-State Operators

Cresco Labs operates 11 Ohio dispensaries under the Sunnyside brand following its May 2024 acquisition of Verdant Creations for $47 million, making it the state's largest MSO by retail footprint. The company also holds a Level I cultivation license in Yellow Springs producing approximately 8,000 pounds annually of flower and trim for wholesale and vertical integration. Curaleaf operates seven Ohio dispensaries and a processing facility in Ravenna, entering the market through its November 2023 acquisition of Bloom Medicinals for $37 million. The company focuses on branded products including Select vape cartridges and Curaleaf-branded flower, capturing approximately 12% of the adult-use market by volume as of August 2026. Verano Holdings operates five dispensaries under the Zen Leaf brand and a 25,000-square-foot cultivation facility in Newark, producing popular strains including Modified Grapes and Mag Landrace. The company reported $31 million in Ohio revenue for Q2 2026, representing 8% of its national sales.

Ohio Operators and Advocacy Groups

Buckeye Relief, an Ohio-based cultivator founded in 2018, operates the state's largest single cultivation facility at 200,000 square feet in Eastlake, producing approximately 18,000 pounds annually. The company's Lemon Dosidos and Willies Reserve strains consistently rank among the top five sellers statewide. Buckeye Relief supplies approximately 40 dispensaries through wholesale agreements. The Ohio Cannabis Coalition, formed in January 2024, represents 67 licensed operators advocating for regulatory reforms including home cultivation prohibition maintenance, interstate commerce preparation, and federal rescheduling alignment. The coalition spent $1.2 million on lobbying in 2025, making it the 14th-largest lobbying entity in Ohio.

Opposition and Regulatory Skeptics

The Ohio Prosecuting Attorneys Association, representing all 88 county prosecutors, opposed Issue 2 and continues to advocate for stricter impaired driving standards and workplace protections. The association supported Senate Bill 288, introduced in March 2026, which would establish a 5-nanogram per-milliliter THC blood threshold for DUI prosecutions, aligning Ohio with Colorado and Washington standards. The bill remains in committee as of September 2026.

Legal and Regulatory Framework

Statutory Authority

Ohio Revised Code Chapter 3780, enacted through Issue 2 and codified December 7, 2023, establishes the legal framework for adult-use cannabis including possession limits, licensing categories, and tax structure. Section 3780.01 defines cannabis as all parts of the Cannabis sativa L. plant, distinguishing it from hemp (defined under ORC 928.01 as cannabis with less than 0.3% delta-9 THC by dry weight). Section 3780.21 authorizes the Division of Cannabis Control to issue five license types: cultivator (Level I and Level II), processor, retail dispensary, testing laboratory, and transporter. The statute caps total cultivator licenses at 250 statewide, with no individual or entity permitted to hold more than five dispensary licenses or more than two Level I cultivation licenses. Section 3780.35 establishes a 10% excise tax on gross receipts from adult-use sales, collected at the retail level and distributed as follows: 50% to the Division of Cannabis Control for administrative costs and social equity programs, 36% to municipalities and townships hosting dispensaries, 14% to the Substance Abuse and Addiction Services Fund. Medical cannabis remains subject to state sales tax (5.75%) but exempt from the excise tax.

Possession and Use Limits

Adults 21 and older may possess up to 2.5 ounces of cannabis flower or equivalent amounts of concentrate (15 grams) and edibles (750 milligrams THC) outside the home, with no possession limit at one's residence. ORC 3780.19 defines equivalencies: one gram of concentrate equals 5 grams of flower, and 100 milligrams of THC in edible form equals 1 gram of flower. Possession of 2.5 to 5 ounces constitutes a minor misdemeanor with a maximum $150 fine; possession exceeding 5 ounces remains a felony. Public consumption is prohibited under ORC 3780.22, with violations punishable by a $150 civil fine for first offenses and $250 for subsequent violations within two years. The statute defines public places as any location accessible to the general public, including streets, parks, restaurants, and vehicles, but excludes private residences and licensed consumption lounges (none of which have been licensed as of September 2026).

Employment and Impairment Standards

Ohio law provides no employment protections for cannabis users, permitting employers to maintain zero-tolerance drug policies and terminate employees for positive THC tests regardless of off-duty consumption. ORC 3780.28 explicitly states that the statute does not require employers to permit or accommodate cannabis use, distinguish between medical and adult-use consumption, or prohibit employers from disciplining employees for workplace impairment. The statute defines impairment as "under the influence of cannabis to a degree that renders the person incapable of safely performing work duties," but establishes no specific THC threshold. Law enforcement may conduct field sobriety tests and request blood or urine samples from drivers suspected of impairment, with refusal resulting in automatic one-year license suspension under ORC 4511.19.

Federal Conflict and Banking Challenges

Cannabis remains a Schedule I controlled substance under the federal Controlled Substances Act (21 U.S.C. § 812), creating legal conflicts that prevent Ohio operators from accessing traditional banking services and claiming standard business deductions. Most Ohio dispensaries operate on a cash-only or limited-debit basis, as federally insured banks risk prosecution under 18 U.S.C. § 1956 (money laundering) and 18 U.S.C. § 1957 (monetary transactions in property derived from specified unlawful activity) for serving cannabis businesses. Internal Revenue Code Section 280E prohibits businesses trafficking in Schedule I or II substances from deducting ordinary business expenses, limiting Ohio operators to cost-of-goods-sold deductions. This results in effective federal tax rates of 60-75% for profitable operators, significantly higher than the 21% corporate rate applied to legal businesses. The U.S. Department of Justice maintains the Cole Memorandum framework (rescinded in 2018 but informally followed), which deprioritizes federal enforcement in states with robust regulatory systems that prevent diversion, youth access, and interstate trafficking. No Ohio operator has faced federal prosecution as of September 2026, though the legal risk remains.

State-by-State Context

Ohio's Regional Position

Ohio is the only state bordering both Michigan (which legalized adult-use cannabis in 2018) and West Virginia (which maintains cannabis prohibition) to operate a dual medical and adult-use program, creating complex interstate dynamics. Michigan's mature market, with approximately 1,400 licensed retailers and wholesale flower prices averaging $800-1,000 per pound, exerts downward price pressure on Ohio operators near the border. Toledo and Cleveland dispensaries report 15-20% of customers are Michigan residents seeking lower prices and higher potency products. Pennsylvania, which shares a 300-mile border with Ohio, operates a medical-only program serving approximately 425,000 registered patients. Pennsylvania residents accounted for an estimated 8-10% of Ohio adult-use sales in the first year, according to Division of Cannabis Control transaction data showing concentrations of out-of-state driver's licenses at dispensaries in Youngstown, Steubenville, and East Liverpool. Pennsylvania's adult-use legalization efforts failed in the 2025-2026 legislative session despite support from Governor Josh Shapiro.

Midwest Comparison

Among Midwest states, Ohio's 10% excise tax rate is lower than Illinois (33% of retail price for adult-use products) but higher than Michigan (10% excise tax plus 6% sales tax). Ohio's prohibition on home cultivation aligns with Illinois and New Jersey but contrasts with Michigan, Missouri, and Montana, which permit six-plant home grows for adults.

State	Adult-Use Launch	Excise Tax Rate	Home Cultivation	Possession Limit
Ohio	August 2024	10%	Prohibited	2.5 oz
Michigan	December 2019	10% + 6% sales tax	12 plants	2.5 oz
Illinois	January 2020	33% of retail price	5 plants (medical only)	1 oz (non-resident)
Missouri	February 2023	6%	6 plants	3 oz

Market and Business Implications

Revenue and Market Size

Ohio's adult-use program generated $274 million in first-year sales (August 2024 - August 2025), producing approximately $27.4 million in excise tax revenue and $16 million in state sales tax. The Division of Cannabis Control projects sales growth to $425-475 million in year two as supply constraints ease and consumer awareness increases, positioning Ohio as the 10th-largest adult-use market nationally by 2027. Medical sales totaled $312 million in the 12 months following adult-use launch, down from $367 million in the prior year, as approximately 35,000 patients transitioned to recreational purchasing. Total market size (medical plus adult-use) reached $586 million, representing 4.2% penetration of Ohio's estimated $14 billion total cannabis consumption including illicit market activity.

Wholesale Pricing Dynamics

Wholesale flower prices declined from an average of $2,400 per pound in August 2024 to $1,500 per pound in August 2026, compressing margins for non-vertically integrated cultivators. The decline reflects increased production capacity, with total licensed canopy expanding from 1.5 million square feet in July 2024 to 2.1 million square feet in August 2026, and improved cultivation efficiency as operators optimized environmental controls and genetics. Premium strains including Jealousy, Gush Mints, and Donny Burger command wholesale prices of $1,800-2,200 per pound, while commodity flower trades at $1,200-1,400 per pound. Concentrate wholesale prices range from $8-15 per gram for distillate to $18-28 per gram for live resin and rosin, with branded products commanding 20-30% premiums over white-label offerings.

MSO Consolidation and Capital Flows

Multi-state operators completed 14 Ohio acquisitions totaling $287 million between January 2024 and August 2026, consolidating the market around vertically integrated players with national brand portfolios. Transaction multiples averaged 9.2x trailing twelve-month EBITDA for profitable dispensary portfolios and 1.8x revenue for cultivation assets, reflecting investor preference for retail over production exposure. Cresco Labs' $47 million acquisition of Verdant Creations in May 2024 valued the 11-dispensary chain at $4.3 million per location, below the $5-7 million per-store valuations observed in mature markets but reflecting Ohio's early-stage growth trajectory. Curaleaf's $37 million Bloom Medicinals acquisition in November 2023 included a 25,000-square-foot cultivation facility, providing vertical integration that improved gross margins by an estimated 12-15 percentage points. Private equity and venture capital firms deployed approximately $180 million into Ohio cannabis between January 2024 and August 2026, according to data from Viridian Capital Advisors, with investments concentrated in multi-unit retail operators and branded product companies. Notable transactions included Chicago-based Green Thumb Industries' $28 million investment in Ohio Pure Extracts (a processor specializing in live resin vape cartridges) and New York-based Poseidon Asset Management's $35 million acquisition of a five-dispensary portfolio in Columbus and Cincinnati.

Employment and Economic Impact

Ohio's cannabis industry employed approximately 15,000 workers as of August 2026, including 6,200 in retail, 4,800 in cultivation, 2,400 in processing, and 1,600 in ancillary services such as testing, security, and compliance consulting. Average wages range from $16-19 per hour for entry-level budtender and cultivation technician positions to $75,000-120,000 annually for master growers, extraction specialists, and compliance directors. The Ohio Cannabis Workers Union, affiliated with the United Food and Commercial Workers (UFCW) Local 1059, represents approximately 1,200 workers at 18 facilities including Cresco Labs' Yellow Springs cultivation site and five Curaleaf dispensaries. Union contracts negotiated in 2025-2026 established starting wages of $18.50 per hour for budtenders (compared to $15-16 at non-union locations), employer-funded health insurance, and grievance procedures.

What Experts Say

Tom Haren, a cannabis attorney with Frantz Ward in Cleveland, said the Division of Cannabis Control's enforcement approach balances public safety with industry growth. According to Haren, the September 2026 dispensary closure demonstrates that regulators will act decisively when patient safety is at risk, but the overall compliance framework remains less punitive than California or Massachusetts, where minor violations can trigger license suspensions. Haren noted that Ohio's inventory tracking system, which requires real-time reporting of all transactions to the state's METRC database, provides transparency that helps identify diversion and contamination risks before they escalate. Amber Senter, executive director of the Supernova Women cannabis business network, said Ohio's social equity program lags behind Illinois and New Jersey in providing meaningful opportunities for communities disproportionately impacted by prohibition. According to Senter, the Division of Cannabis Control's social equity license category, which offers fee reductions and technical assistance to applicants with prior cannabis convictions or residence in high-enforcement ZIP codes, has resulted in only 11 social equity licensees as of August 2026. Senter attributed the low participation to insufficient access to capital, as most banks remain unwilling to lend to cannabis businesses regardless of social equity status, and competition from well-capitalized MSOs that can outbid equity applicants for prime real estate and equipment. Andrew Freedman, a cannabis policy consultant and former director of Colorado's marijuana coordination office, said Ohio's decision to prohibit home cultivation reduces regulatory complexity but limits consumer choice and maintains higher prices. According to Freedman, Colorado's experience shows that home cultivation accounts for approximately 15-20% of total consumption in mature markets, with most home growers cultivating 2-4 plants for personal use rather than commercial-scale operations. Freedman noted that Ohio's prohibition may face legal challenges under state constitutional protections for personal autonomy, similar to litigation in Washington, D.C., where courts upheld home cultivation bans, and Alaska, where courts struck them down. Beau Whitney, senior economist at Whitney Economics, said Ohio's wholesale price decline of 35-40% in the first year aligns with patterns observed in other new adult-use markets but may stabilize at $1,200-1,500 per pound rather than falling to the $600-800 range seen in mature West Coast markets. According to Whitney, Ohio's prohibition on interstate commerce and relatively high barriers to entry (including $180,000 Level I cultivation license fees) will prevent the oversupply conditions that drove prices below $500 per pound in Oregon and Oklahoma. Whitney projected that Ohio's market will reach equilibrium at 2.8-3.2 million square feet of licensed canopy, supporting annual sales of $650-750 million by 2028.

What's Next

Near-Term Regulatory Decisions (September 2026 - March 2027)

The Division of Cannabis Control will release findings from its investigation into the September 2026 dispensary closure by October 15, 2026, according to a statement from Director James Canepa. The investigation focuses on whether contaminated product passed through the state's testing protocols or if the adverse reactions resulted from consumer misuse or pre-existing conditions. If testing failures are identified, the Division may implement enhanced screening requirements including expanded mycotoxin panels and lower action limits for pesticide residues. The Division will open a second application window for new adult-use licenses in January 2027, prioritizing social equity applicants and operators in underserved counties. The application window will remain open for 90 days, with licenses awarded through a merit-based scoring system evaluating business plans, capitalization, and community impact rather than lottery. The Division projects issuing 30-50 new dispensary licenses and 10-15 new cultivation licenses, increasing total market capacity by approximately 15%.

Legislative Developments (2027 Session)

House Bill 89, introduced in February 2026 and carried over to the 2027 session, would establish licensed consumption lounges permitting on-site cannabis use in designated facilities. The bill requires lounges to obtain a $50,000 annual license, prohibit alcohol sales, and implement ventilation systems meeting American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) Standard 62.1. The bill passed the House Commerce and Labor Committee 9-4 in June 2026 but faces uncertain prospects in the full House, where leadership has not scheduled a floor vote. Senate Bill 312, introduced in April 2026, would permit medical cannabis patients to cultivate up to six plants at home while maintaining the prohibition for adult-use consumers. The bill reflects a compromise between cultivation advocates and law enforcement, who argue that limiting home grows to registered patients provides a regulatory framework for tracking production. The bill remains in the Senate Judiciary Committee as of September 2026, with Chairman Nathan Manning indicating he will hold hearings in October 2026.

Federal Rescheduling Impact

The U.S. Drug Enforcement Administration's proposed rule to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act, published in the Federal Register on May 21, 2024, would eliminate Internal Revenue Code Section 280E tax penalties for Ohio operators if finalized. The DEA's administrative law judge hearings concluded in July 2026, with a final rule expected in Q1 2027 following review of public comments and expert testimony. If cannabis is rescheduled to Schedule III, Ohio operators would gain access to standard business deductions for rent, salaries, marketing, and other operating expenses, reducing effective federal tax rates from 60-75% to approximately 21-28%. This would improve after-tax profitability by an estimated 40-50% for vertically integrated operators and 25-35% for dispensary-only businesses, according to analysis by Viridian Capital Advisors. Rescheduling would not resolve banking access challenges, as cannabis would remain federally prohibited for non-medical purposes, but would likely encourage more regional banks to serve the industry.

Market Maturation Scenarios (2027-2030)

Ohio's adult-use market is projected to reach $650-750 million in annual sales by 2028, representing 5.5-6.5% penetration of total cannabis consumption including illicit market activity. Growth drivers include continued conversion of medical patients to adult-use purchasing (projected to stabilize at 60-65% of the current medical patient base), increased product variety as processors launch branded edibles and beverages, and geographic expansion as additional municipalities opt in to hosting dispensaries. Downside risks include federal enforcement changes under a new presidential administration, continued banking access limitations that constrain capital availability, and competition from neighboring states if Pennsylvania or Kentucky legalize adult-use sales. Pennsylvania's legalization would reduce Ohio's border-market advantage, potentially decreasing sales by 8-10% in eastern counties, while Kentucky legalization would have minimal impact given that state's smaller population and limited border overlap.

Further Reading

• Ohio Revised Code Chapter 3780 (Adult Use Cannabis Law): https://codes.ohio.gov/ohio-revised-code/chapter-3780
• Ohio Division of Cannabis Control Official Website: https://medicalmarijuana.ohio.gov
• Issue 2 Full Text and Voter Guide (Ohio Secretary of State, 2023): https://www.ohiosos.gov/elections/voters/issues-and-ballot/
• Ohio Medical Marijuana Control Program Annual Report 2025: https://medicalmarijuana.ohio.gov/annual-reports
• DEA Notice of Proposed Rulemaking on Cannabis Rescheduling (Federal Register, May 21, 2024): https://www.federalregister.gov/documents/2024/05/21/
• Viridian Capital Advisors Ohio Cannabis Market Report Q2 2026: https://www.viridianca.com/research
• NORML Ohio State Laws and Penalties: https://norml.org/laws/ohio/
• Marijuana Policy Project Ohio Campaign Archive: https://www.mpp.org/states/ohio/
• Ohio Cannabis Coalition Policy Positions: https://www.ohiocannabiscoalition.com
• Whitney Economics Ohio Market Analysis 2026: https://www.whitneyeconomics.com/ohio-cannabis